These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8845048)

  • 1. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis.
    Brod SA; Khan M
    J Autoimmun; 1996 Feb; 9(1):11-20. PubMed ID: 8845048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
    Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
    Meyer AL; Benson JM; Gienapp IE; Cox KL; Whitacre CC
    J Immunol; 1996 Nov; 157(9):4230-8. PubMed ID: 8892661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
    Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
    Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma.
    Furlan R; Bergami A; Cantarella D; Brambilla E; Taniguchi M; Dellabona P; Casorati G; Martino G
    Eur J Immunol; 2003 Jul; 33(7):1830-8. PubMed ID: 12811843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of selective IL-6 inhibitor Am-80 on experimental autoimmune encephalomyelitis in DA rats.
    Wang T; Nagai H; Bouda K; Matsuura S; Takaoka Y; Niwa S; Homma T; Tanaka H; Shudo K
    Acta Pharmacol Sin; 2000 Nov; 21(11):967-76. PubMed ID: 11501064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons.
    Brod SA; Scott M; Burns DK; Phillips JT
    J Interferon Cytokine Res; 1995 Feb; 15(2):115-22. PubMed ID: 8590314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-gamma antibodies alters trypanosome-susceptible mice to a resistant-like phenotype.
    Uzonna JE; Kaushik RS; Gordon JR; Tabel H
    J Immunol; 1998 Nov; 161(10):5507-15. PubMed ID: 9820527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice.
    Verbeek R; van Tol EA; van Noort JM
    Biochem Pharmacol; 2005 Jul; 70(2):220-8. PubMed ID: 15946653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-gamma-dependent way.
    Berghmans N; Dillen C; Heremans H
    J Neuroimmunol; 2006 Jul; 176(1-2):63-75. PubMed ID: 16764944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsicum ethanol extracts and capsaicin enhance interleukin-2 and interferon-gamma production in cultured murine Peyer's patch cells ex vivo.
    Takano F; Yamaguchi M; Takada S; Shoda S; Yahagi N; Takahashi T; Ohta T
    Life Sci; 2007 Apr; 80(17):1553-63. PubMed ID: 17306834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12.
    Kohno K; Kataoka J; Ohtsuki T; Suemoto Y; Okamoto I; Usui M; Ikeda M; Kurimoto M
    J Immunol; 1997 Feb; 158(4):1541-50. PubMed ID: 9029088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ingested interferon alpha induces Mx mRNA.
    Brod SA; Nelson L; Jin R; Wolinsky JS
    Cytokine; 1999 Jul; 11(7):492-9. PubMed ID: 10419650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline.
    Bright JJ; Du C; Coon M; Sriram S; Klaus SJ
    J Immunol; 1998 Dec; 161(12):7015-22. PubMed ID: 9862738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis.
    Wildbaum G; Youssef S; Grabie N; Karin N
    J Immunol; 1998 Dec; 161(11):6368-74. PubMed ID: 9834127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
    Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
    J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis.
    Chiba K; Kataoka H; Seki N; Shimano K; Koyama M; Fukunari A; Sugahara K; Sugita T
    Int Immunopharmacol; 2011 Mar; 11(3):366-72. PubMed ID: 20955831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.
    Morini M; Roccatagliata L; Dell'Eva R; Pedemonte E; Furlan R; Minghelli S; Giunti D; Pfeffer U; Marchese M; Noonan D; Mancardi G; Albini A; Uccelli A
    J Neuroimmunol; 2004 Mar; 148(1-2):146-53. PubMed ID: 14975595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis.
    Brod SA; Khan M; Kerman RH; Pappolla M
    J Neuroimmunol; 1995 Apr; 58(1):61-9. PubMed ID: 7537281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.